- Release Date: 04/06/19 08:31
- Summary: PAR REPORTS SUCCESSFUL ROSS RIVER PHASE 2 CLINICAL TRIAL
- Price Sensitive: Yes
- Download Document 408.29KB
- Forums
- ASX - By Stock
- PAR
- Ann: PAR REPORTS SUCCESSFUL ROSS RIVER PHASE 2 CLINICAL TRIAL
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
5.93%
!
31.3¢

Ann: PAR REPORTS SUCCESSFUL ROSS RIVER PHASE 2 CLINICAL TRIAL
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
31.3¢ |
Change
0.018(5.93%) |
Mkt cap ! $124.1M |
Open | High | Low | Value | Volume |
30.0¢ | 31.5¢ | 30.0¢ | $135.6K | 445.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 48466 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.5¢ | 209641 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 48466 | 0.310 |
5 | 43945 | 0.305 |
9 | 80661 | 0.300 |
16 | 170692 | 0.295 |
17 | 413809 | 0.290 |
Price($) | Vol. | No. |
---|---|---|
0.315 | 209634 | 5 |
0.320 | 24019 | 3 |
0.325 | 14610 | 2 |
0.330 | 8760 | 2 |
0.335 | 15000 | 1 |
Last trade - 13.48pm 13/08/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |